China Renji Medical Group (00648) said it agreed to sell 20% equity interest in Wintin International Limited at the initial consideration of HK$26 million in cash (subject to adjustment) to Golden River Associates Ltd.
It is estimated that there will be a gain of HK$1 million from the disposal. Upon completion, China Renji will remain as the single largest shareholder of Wintin.
Wintin is an investment holding company and, through its subsidiaries, is principally engaged in the medical network business of the Group in the PRC.
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情
